16 May 2012
Last updated at 07:12
By James Gallagher
Health and science reporter, BBC News
Abiraterone has been shown to extend life for more than three months
A drug for advanced prostate cancer is likely to be approved for NHS use in England and Wales after the medical watchdog reversed an earlier decision.
Abiraterone, which
No comments:
Post a Comment